Alban A, Gyldmark M, Pedersen A V, Søgaard J
Danish Institute for Health Services Research and Development, Copenhagen, Denmark.
Pharmacoeconomics. 1997 Dec;12(6):627-36. doi: 10.2165/00019053-199712060-00003.
Standards for economic evaluation have now been proposed in several countries. The background for this article is a report commissioned in 1994 by the Danish health authorities (the National Board of Health and the Danish Ministry of Health) on the state of the art of economic evaluation: are the methods ready to be used for systematic decision-making in the Danish healthcare sector? The themes of this article are the attitude towards economic evaluation of medical technologies and healthcare services in Denmark, the areas for application and the desirability and feasibility of a standard set of methods for conducting economic evaluations. In addition, the current state of methodologies in economic evaluation is briefly outlined. On the background of a roundtable discussion of interested parties, the Danish health authorities have decided to introduce economic evaluation of new pharmaceutical products, on a voluntary basis for 2 to 3 years, when application has been made for public reimbursement.
现在，几个国家已经提出了经济评估标准。本文的背景是丹麦卫生当局（国家卫生局和丹麦卫生部）于1994年委托撰写的一份关于经济评估技术现状的报告：这些方法是否准备好用于丹麦医疗保健部门的系统决策？本文的主题是丹麦对医疗技术和医疗服务经济评估的态度、应用领域以及一套进行经济评估的标准方法的可取性和可行性。此外，还简要概述了经济评估方法的当前状况。在相关各方进行圆桌讨论的背景下，丹麦卫生当局决定在新药品申请公共报销时，在2至3年的自愿基础上引入对新药品的经济评估。
